Lmr Partners LLP Bei Gene, Ltd. Transaction History

Lmr Partners LLP

$10.5 Billion
Q2 2025

A detailed history of Lmr Partners LLP transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Lmr Partners LLP holds 78,369 shares of BGNE stock, worth $17.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

78,369

Previous 24,658 217.82%

Holding current value

$17.8 Million

Previous $5.59 Million 217.84%

% of portfolio

0.17%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	N/A	53,711 Added 217.82%	78,369 $17.8 Million
Q1 2025 May 15, 2025	BUY	$175.1 - $226.71 $3.92 Million - $5.07 Million	22,373 Added 979.12%	24,658 $5.59 Million
Q4 2024 Feb 14, 2025	SELL	$174.72 - $246.04 $795,500 - $1.12 Million	-4,553 Reduced 66.58%	2,285 $422,000
Q3 2024 Nov 07, 2024	BUY	$143.93 - $224.51 $984,193 - $1.54 Million	6,838 New	6,838 $1.54 Million
Q1 2024 May 15, 2024	BUY	$141.8 - $181.47 $2.2 Million - $2.82 Million	15,520 Added 451.95%	18,954 $2.96 Million
Q4 2023 Feb 14, 2024	SELL	$158.67 - $201.58 $1.66 Million - $2.11 Million	-10,447 Reduced 75.26%	3,434 $619,000
Q3 2023 Nov 14, 2023	BUY	$179.87 - $225.13 $2.5 Million - $3.13 Million	13,881 New	13,881 $2.5 Million
Q2 2022 Aug 15, 2022	BUY	$121.11 - $216.05 $1.59 Million - $2.83 Million	13,108 New	13,108 $2.12 Million
Q1 2022 May 16, 2022	SELL	$146.52 - $269.56 $869,010 - $1.6 Million	-5,931 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $1.02 Million - $1.61 Million	-4,123 Reduced 41.01%	5,931 $1.61 Million
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $2.51 Million - $4.05 Million	10,054 New	10,054 $3.65 Million
Q2 2020 Aug 14, 2020	SELL	$123.9 - $195.41 $1.51 Million - $2.38 Million	-12,159 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$115.78 - $208.34 $733,003 - $1.32 Million	6,331 Added 108.63%	12,159 $2.02 Million
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $702,915 - $864,234	5,828 New	5,828 $714,000

Others Institutions Holding BGNE

# of Institutions

268

Shares Held

32.2M

Call Options Held

113K

Put Options Held

106K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account